SXTC (China SXT Pharmaceuticals) EPS (Basic): $-36.26 (TTM As of Sep. 2025)


SXTC China SXT Pharmaceuticals Inc SXTC
26 GF Score
Price $2.35
! 5 Warning Signs
View Full Analysis

What is China SXT Pharmaceuticals EPS (Basic)?

China SXT Pharmaceuticals SXTC -7.48% 26 EPS (Basic) is $-36.26 as of Sep. 2025. GuruFocus rates SXTC with a GF Score™ of 26/100. The stock has 5 warning signs investors should review.

China SXT Pharmaceuticals's basic earnings per share (Basic EPS) for the six months ended in Sep. 2025 was $-9.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2025 was $-36.26.

China SXT Pharmaceuticals's EPS (Diluted) for the six months ended in Sep. 2025 was $-9.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2025 was $-36.26.

China SXT Pharmaceuticals's EPS without NRI for the six months ended in Sep. 2025 was $-9.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2025 was -36.26.

During the past 12 months, China SXT Pharmaceuticals's average EPS without NRIGrowth Rate was -101.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 84.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was 77.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 9 years, China SXT Pharmaceuticals's highest 3-Year average EPS without NRI Growth Rate was 84.00% per year. The lowest was 72.30% per year. And the median was 75.20% per year.

China SXT Pharmaceuticals  (NAS:SXTC) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

China SXT Pharmaceuticals EPS (Basic) Related Terms

China SXT Pharmaceuticals EPS (Basic) Historical Data

* Premium members only.

The historical data trend for China SXT Pharmaceuticals's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

China SXT Pharmaceuticals EPS (Basic) Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only -109,927.32 -85,613.36 -15,576.83 -1,676.70 -348.15

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16,000.26 3,570.14 -300.00 -27.26 -9.00
SXTC
26GF Score
China SXT Pharmaceuticals Inc SXTC
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

China SXT Pharmaceuticals EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

China SXT Pharmaceuticals's Basic EPS for the fiscal year that ended in Mar. 2025 is calculated as

Basic EPS (A: Mar. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-3.304-0)/0.009
=-367.11

China SXT Pharmaceuticals's Basic EPS for the quarter that ended in Sep. 2025 is calculated as

Basic EPS (Q: Sep. 2025 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-6.369-0)/0.774
=-8.23

EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-36.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $-36.26 mean?
China SXT Pharmaceuticals (SXTC) has a EPS (Basic) of $-36.26 as of Sep. 2025. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China SXT Pharmaceuticals and its competitors.
Is China SXT Pharmaceuticals' EPS (Basic) too high?
China SXT Pharmaceuticals' current EPS (Basic) is $-36.26. Overall, China SXT Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China SXT Pharmaceuticals' EPS (Basic) compare to YCBD and CVSI?
China SXT Pharmaceuticals' EPS (Basic) of $-36.26 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on China SXT Pharmaceuticals and its competitors. China SXT Pharmaceuticals's current EPS (Basic) is $-36.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China SXT Pharmaceuticals stock overvalued right now?
China SXT Pharmaceuticals (SXTC) has a current EPS (Basic) of $-36.26. The current EPS (Basic) is $-36.26. China SXT Pharmaceuticals' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For China SXT Pharmaceuticals (SXTC), the current EPS (Basic) is $-36.26 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

China SXT Pharmaceuticals Business Description

Address No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
26GF Score

Get the complete analysis for SXTC

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price